Per-patient costs of metastatic prostate cancer estimated at $31,427
Dec 27, 2022
An increase in annual attributable costs was observed over time, from $28,311 in 2007-2013 to $37,055 in 2014-2017.
Plant-based diets tied to long-term health benefits
May 15, 2024
The benefits include a better cardiometabolic risk profile as well as lower mortality.
One-quarter of older advanced cancer patients taking eight or more drugs
Mar 20, 2023
Polypharmacy was tied to an increased risk for adverse treatment outcomes, such as toxicity and early treatment discontinuation.
Culturally tailored program increases colonoscopy completion
Feb 07, 2022
The overall rate of colonoscopy completion was 85% in the Hispanic population; the reasons for cancellation and no-show included cost.
2019 to 2020 saw 16.8 percent increase in U.S. death rate
Dec 22, 2021
The two leading causes of death continued to be heart disease and cancer, with COVID-19 the third leading cause of death in 2020.
In-home chemo infusion poses numerous health risks, groups insist
By
John O'Connor
Sep 24, 2020
Although many healthcare professionals see a bright future for telehealth and expanded care in home care settings, oncology groups are drawing the line at chemotherapy infusions.
Global economic cost of cancer estimated to be $25.2 trillion from 2020 to 2050
Feb 24, 2023
75.1% of cancer deaths occur in low- and middle-income countries, which account for 49.5% of economic cost.
Legislation to boost home infusion receives kudos
By
Diane Eastabrook
Aug 11, 2021
The National Home Infusion Association (NHIA) is praising bipartisan legislation that would ensure that Medicare patients continue gaining access to home infusion therapies that require the use of an infusion...
Additional benefit seen for colonoscopy versus sigmoidoscopy
Mar 05, 2024
In recent study, fewer colorectal cancer cases and deaths per 100,000 person-years were observed.
Deficits in cancer screening at most facilities during pandemic
Mar 22, 2022
More than 80% of facilities reported deficits in monthly screening for colorectal cancer; there was a mean relative change of −17.7% in the monthly screening test volume.